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Background
We aim to evaluate the proportion of transitional immature
and CD21low B cells in patients with Ataxia-telangiectasia
(AT), a complex disease with humoral and cellular immune
dysfunction.
Methods
Blood samples were obtained from 18 AT patients and
15 age-sex-matched controls (C). This study was
approved by the Medical Ethic Committee of the
Federal University of Sao Paulo. Total numbers of T, B,
and NK cells were enumerated from whole blood sam-
ples using TruCount Tubes. Peripheral blood mononuc-
lear cells (PBMC) were cryopreserved, thawed and
stained with conjugated monoclonal antibodies: anti-
CD19-PerCP anti-CD3-APCCy7, anti-CD24-PE, anti-
CD21-APC, anti-CD38-PECy7. Five-color flow cyto-
metric immunophenotyping was performed on a BD
LSRFortessa (BD Biosciences), and data were analyzed
with FlowJo software (TreeStar, Stanford University,
CA). Transitional B cells were characterized as CD3-
CD19+CD24hiCD38hi, and CD21low B cells as CD3-
CD19+CD21loCD38lo. Statistical analysis was performed
with SPSS 20.0 and STATA 12, and a significance
threshold of <0.05 was used.
Results
From 18 patients, 15 were male and 3 female, aged from
5 to 25 years old. There were 3 pairs of siblings. Con-
sanguinity was present between 2 parents. Ten of them
are being treated with immunoglobulin replacement
therapy. One of them had recovered from a neoplastic
hematologic disease. The total number of lymphocytes
was reduced in AT patients (928 - 4579 cel/mm3)
compared to controls (1646 – 6601 cel/mm3) (p=0.001).
Total CD3+ (AT = 1163.8 cel/mm3; C= 2247.2 cel/mm3;
p<0.001), CD4+ (AT = 531.4 cel/mm3; C= 1153.3 cel/
mm3; p<0.001) and CD8+ (AT = 507.6 cel/mm3; C=
880.3 cel/mm3; p=0.007) numbers were decreased as
well.B cells counts also showed a reduction compared
with healthy controls (AT = 118.7 cel/mm3; C= 649.3
cel/mm3; p<0.001). By contrast, natural killer numbers
were increased (AT = 583.9 cel/mm3; C= 357.3 cel/
mm3; p=0.04). Proportion of Transitional B cells was
reduced compared with those seen in healthy control
subjects (AT= 2.2%; C= 7.3%; p=0.001). On the other
hand, the CD21low B Cells showed an increased propor-
tion (AT= 25%; C=4.9%; p<0.001).
Conclusions
Patients with AT had disturbed B-cell homeostasis as
evidenced by low transitional B cells and a large propor-
tion CD21low B cells.
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